Apple Hits ₹8.5L Cr Revenue as iPhone 17 Sales Soar
Apple's Q4 earnings reveal massive ₹8.5 lakh crore revenue and ₹2.3 lakh crore profit as iPhone 17 sales explode. Discover how India's premium smartphone market is fueling this historic growth.
Category : Search result: pharma profit growth
ITC Q2 Profit Jumps 10% to ₹5,199 Crore
ITC delivers impressive Q2 performance with 10% profit surge to ₹5,199 crore, driven by strong FMCG and hotel segments. Revenue climbs despite cigarette volume pressure. Full analysis inside.
Periwinkle for Hair Growth: Sadabahar Beauty Secrets
Discover the ancient Ayurvedic secret of using Periwinkle (Sadabahar) flowers for dramatic hair growth. Learn simple, effective methods to transform your hair care routine naturally.
Sharda Cropchem Q2 Profit Jumps 75%, Revenue Up 20%
Agrochemical major Sharda Cropchem delivers stellar Q2 performance with massive profit growth and strong revenue increase, showcasing robust demand in global markets.
Cipla Shares Fall 4% After Q2 Results
Cipla's stock faced significant pressure after Q2 FY2025 results revealed margin pressures despite revenue growth. Discover the key factors behind the 4% decline and what analysts are saying about the pharmaceutical giant's future prospects.
US Push for Affordable Biotech Drugs: India's Opportunity
Federal health officials are accelerating efforts to bring cheaper biotech drugs to market, potentially transforming treatment access and creating new opportunities for Indian pharmaceutical companies.
NTPC Green Energy Q2 Profit Soars 135% to ₹86.38 Crore
NTPC Green Energy reports stellar Q2 performance with 135% jump in net profit and 25% revenue growth, signaling strong momentum in renewable energy sector.
India Bans Fraudulent Pharma Licenses in Major Reform
India implements sweeping regulatory reforms to combat fraudulent pharmaceutical manufacturing licenses, enhancing drug safety standards for domestic and international markets including US and EU.
Manaksia Metals Profit Jumps 491% in Q2 FY26
Manaksia Coated Metals Industries reports spectacular Q2 FY26 results with net profit skyrocketing 491% year-on-year to ₹14 crore, showcasing remarkable financial turnaround.
UnitedHealth Stock Surges 4% on Upbeat Profit Forecast
UnitedHealth Group shares surge over 4% after raising 2025 profit outlook. CEO Stephen Hemsley outlines aggressive growth roadmap targeting significant expansion by 2026.
Tata Capital Q2: Profit Dips 6.5%, NII Up 76%
Tata Capital reports mixed Q2 FY25 results with 6.5% profit decline but strong 76% NII growth. Discover the complete financial breakdown and strategic insights.
Newgen Software Q2: Revenue up 11%, Profit jumps 16%
Newgen Software Technologies reports impressive Q2 FY2024 results with 11% revenue growth and 16% profit surge, driven by robust demand for digital transformation solutions.
CarTrade Tech Q2 Profit Zooms 109% to ₹64 Crore
CarTrade Tech delivers stellar Q2 performance with highest-ever revenue and massive profit surge, showcasing robust growth in India's auto-tech sector.
TTK Prestige Q2 Profit Soars 22% to ₹63.20 Cr
TTK Prestige delivers stellar Q2 performance with robust profit growth and strong revenue increase, showcasing exceptional demand for kitchen appliances across India.
Sundaram Home Finance Q2 Profit Hits ₹75 Crore
Sundaram Home Finance reports impressive ₹75 crore net profit in Q2 FY2024, showcasing strong growth in disbursements and assets under management despite market challenges.
TMB Q2 FY26: Net Profit Up 4.9%
Tamilnad Mercantile Bank reports impressive 4.9% growth in net profit for Q2 FY26, showcasing robust financial health and strategic growth initiatives in the competitive banking sector.
Kotak Bank Q2 Profit ₹4,468 Cr, Loans & Deposits Grow
Kotak Mahindra Bank reports robust Q2 FY26 performance with consolidated profit reaching ₹4,468 crore. Strong growth in loan book and deposits signals healthy banking sector recovery. Read full analysis of financial results and future outlook.
Mukul Agrawal's ₹200 Cr Pharma Stock Bet Revealed
Discover why prominent investor Mukul Agrawal is betting big on a small-cap pharma company with massive growth potential. Get exclusive insights into his latest portfolio move and what it means for retail investors.
Kotak Bank Q2 Profit Dips 3% to ₹3,253 Crore
Kotak Mahindra Bank reports 3% decline in Q2 net profit to ₹3,253 crore despite NII growth. Discover the factors behind the mixed performance and what lies ahead for the private sector lender.
Kotak Bank Q2: Profit Down 2%, NII Up 4%
Kotak Mahindra Bank reports mixed Q2 FY2025 results with net profit declining 2% to ₹3,253 crore while Net Interest Income grows 4%. Discover the key drivers behind these numbers and what they mean for investors.
Dr. Reddy's Legacy: Transforming Indian Pharma
Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.
Airtel & Jio Set for ROCE Surge: ICICI Securities
India's telecom giants Airtel and Reliance Jio are entering a high-growth phase with rising ROCE and strong cash flows, according to ICICI Securities analysis. Discover how tariff hikes and market consolidation will drive profitability.
Bangladeshi generic drug slashes rare disease treatment cost by 96%
In a revolutionary healthcare development, Bangladesh's Beximco Pharma launches affordable generic version of lifesaving rare disease drug, dramatically reducing treatment costs from crores to lakhs for patients across South Asia.
Aditya Birla Sun Life AMC Q2: Flat Profit at ₹241 Cr
Aditya Birla Sun Life AMC reports flat Q2 profit of ₹241 crore while revenue climbs 9%. Discover how India's leading asset manager navigated market challenges and maintained strong operational performance.
Sigachi Q2: Profit Halves, Revenue Down 19%
Sigachi Industries faces turbulent quarter with net profit crashing to ₹10.5 crore amid significant revenue decline. What's behind the pharmaceutical giant's disappointing performance?
ITC Hotels Q2 Profit Soars 74% to ₹133 Crore
ITC Hotels delivers stellar Q2 performance with 74% surge in net profit reaching ₹133 crore and 7% revenue growth, showcasing robust recovery in hospitality sector.
Havells Q2: Profit Soars 34%, Revenue Growth Moderates
Havells India reports strong 34% profit growth in Q2 FY25, though revenue growth moderates. Lloyd segment shines while cables business faces challenges. Analysis of what's next for investors.
Cipla Shares Fall 3% Despite Eli Lilly Weight Loss Drug Deal
Cipla's stock faces unexpected pressure despite securing rights to manufacture and distribute Eli Lilly's revolutionary weight loss drug Mounjaro in India. Discover why investors remain cautious.
Cipla-Eli Lilly deal brings weight loss drugs to India
Indian pharmaceutical giant Cipla announces landmark deal with Eli Lilly to manufacture and distribute popular weight loss medications Mounjaro and Zepbound in India under different brand names.
Aurobindo Pharma Expands to Chile with New Subsidiary
Indian pharma giant Aurobindo Pharma establishes new subsidiary in Chile, marking strategic expansion across South American markets with focus on branded prescriptions and over-the-counter medicines.
Page 3 of 4